Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “sans”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 757 records · Page 42
All sourcesNASA NTRSDOE OSTI
DOE OSTI2025

Power-Hardware-in-the-Loop Experiments of a Microgrid With a Grid-Forming Battery Inverter: Preprint

Microgrids continue to proliferate, and they are transitioning away from using conventional generating resources to increasingly relying on inverter-based resources (IBRs) as the voltage and frequency leaders. It is crucial to evaluate the capability of IBRs to provide microgrid stability and resilience. Hardware-in-the-loop (HIL) experiments were conducted to de-risk the field deployment of the San Diego Gas & Electric Company Borrego Springs Microgrid, where a battery inverter was upgraded with grid-forming (GFM) capability to serve as the island leader. This paper presents the HIL experimental results from an HIL test bed that uses a power-hardware-in-the-loop (PHIL) interface with a power inductor that was previously developed for PHIL simulations of microgrids where the inverters need to switch modes, i.e., between grid-following and GFM as the microgrid transitions between grid-connected and islanded operation. This paper presents more details on the interface and HIL simulation results of the planned islanding and load steps in islanded operation to show the effectiveness of the inverters in managing the voltage and frequency.

24 POWER TRANSMISSION AND DISTRIBUTION↗
DOE OSTI2024

12th World Conference on Neutron Radiography Program

This program is for the 12th Annual World Neutron Conference hosted by INL, held in Idaho Falls. Included is the conference schedule, abstracts from presenters, outings, a tour of EBR-1, and facilities at MFC including: TREAT, HFEF, and IMCL. INL researcher abstracts are found on the following pgs: 26, 42, 52, 103, 119, 169, 170, 173, and 182. The 12th World Conference on Neutron Radiography (WCNR-12) is an international forum that brings together researchers, engineers, industry practitioners and university students to promote, discuss and disseminate a wide range of topics in neutron imaging. This weeklong conference focuses on the latest methods, instrumentation and facilities, improvements in data processing and interpretation, and new applications of neutron imaging. Ever-improving neutron imaging instruments and new methods push the frontiers of science and address industrial needs. Many user facilities at large research centers with powerful neutron imaging beamlines address the research needs of an increasingly diverse range of applications. Recent developments in accelerator-based sources could expand the user base for neutron imaging by making compact neutron sources available at facilities beyond large neutron sources at major research centers. Industrial practitioners continue to use neutron imaging for practical industrial applications following industry standards. The World Conference on Neutron Radiography series is organized by the International Society for Neutron Radiography (ISNR) to promote the field of neutron imaging and foster interaction and communication between experts and users in the field (see isnr.de). WCNR-12 continues a series of meetings initiated and started in San Diego, California, in December 1981. In intervals of about four years, the conference moved between the United States, Japan and Europe until the most recent one (WCNR-11) in Sydney, Australia, in 2018 (see previous ISNR proceedings here: https://www.isnr.de/index.php/conferences.)

99 - GENERAL AND MISCELLANEOUS↗
DOE OSTI2025

Security and Privacy Issues in New 5G and 6G Capabilities

Slides for opening INL hosted panel on Security and Privacy Issues in New 5G and 6G Capabilities in the Security and Privacy of Next-Generation Networks (FutureG) Workshop co-located with NDSS Symposium 2025, San Diego, CA.

5G Security↗
DOE OSTI2025

Conduction-Cooled Operation of an SRF Multi-Cell Cavity

The development of compact, SRF-based accelerators for applications beyond research is experiencing notable advancements due to the use of cryocoolers for conduction-cooling instead of traditional liquid cryogens. Following the successful demonstration of a single-cell cavity operated through conduction cooling with three two-stage cryocoolers, Jefferson Lab (JLab) has made strides in the operation of a multi-cell resonator. This milestone paves the way for high-energy applications of compact, conduction-cooled SRF machines. The demonstration, carried out in collaboration with General Atomics, will take place in a dedicated horizontal test cryostat (HTC) at their San Diego facility. This presentation will highlight the technological developments, the latest results, and valuable lessons learned.

Vennekate, J. [Thomas Jefferson National Accelerat↗
DOE OSTI2025

Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2

Genetic disruption of the RAS binding domain (RBD) of phosphoinositide 3-kinase alpha (PI3Kα) impairs the growth of tumors driven by the small guanosine triphosphatase RAS in mice and does not affect PI3Kα’s role in insulin-mediated control of glucose homeostasis. Selectively blocking the RAS-PI3Kα interaction may represent a strategy for treating RAS-dependent cancers as it avoids the toxicity associated with inhibitors of PI3Kα lipid kinase activity. We developed compounds that bind covalently to cysteine 242 in the RBD of PI3K p110α and block RAS activation of PI3Kα activity. In mice, inhibitors slow the growth of RAS mutant tumors and human epidermal growth factor receptor 2–overexpressing tumors, particularly when combined with other inhibitors of the RAS/mitogen-activated protein kinase pathway, without causing hyperglycemia.

Klebba, Joseph E. [Vividion Therapeutics, 5820 Nan↗
DOE OSTI2026

First results of the NEXT-100 detector using $^{83m}$Kr decays

The NEXT collaboration is investigating the double beta decay of $ ^{136}\mathrm Xe$ using high-pressure gas electroluminescent time projection chambers, which provide excellent energy resolution together with a robust topological signature. Operating at the Laboratorio Subterráneo de Canfranc (LSC) and building on the success of the NEXT-White detector, the NEXT-100 apparatus began commissioning in May 2024 and started operation with xenon at a pressure of 4 bar in October 2024. We report here the first results obtained with NEXT-100 using low-energy calibration data from $^{83\text {m}}\textrm{Kr}$ decays, which allow mapping of the detector response in the active volume and monitoring of its stability over time. After homogenizing the light response, we achieve an energy resolution of 4.37% FWHM at 41.5 keV for $^{83\text {m}}\textrm{Kr}$ point-like energy deposits contained in a radius of 425 mm. In a fiducial region representing the operating conditions of NEXT-100 at 10 bar we obtain an improved energy resolution of 4.16% FWHM. These results are in good agreement with that obtained in NEXT-White, and an $E^{-1/2}$ extrapolation to $Q_{\beta \beta }$ yields an energy resolution close to 0.5% FWHM, well below the 1% FWHM design target.

Martínez-Lema, G. [Donostia Intl. Phys. Ctr., San ↗
DOE OSTI2026

Radon-induced backgrounds in the NEXT-100 experiment

The NEXT-100 detector at the LSC aims at the first competitive search for the 0νββ decay using a high-pressure $^{136}$Xe electroluminescent time projection chamber. The first low-background run of NEXT-100 at 3.95 bar has been devoted to the measurement of the radon-induced backgrounds impacting this search. The contributions from both the internal and external airborne radon have been evaluated. The internal $^{222}$Rn activity is found to be (0.95±0.04(stat)±0.09(sys)) Bq/m$^{3}$, while no traces of $^{220}$Rn have been observed. Most of the $^{222}$Rn progeny plate-out on the surface of the cathode of the detector, leading to a rate of Rn-induced $^{214}$Bi of (0.97±0.05(stat)±0.10(sys)) Hz for visible energies above 400 keV. The corresponding background index in the 0νββ region of interest is evaluated as (7.3±1.5(stat)±0.8(sys))×10$^{−4}$ counts/(keV·kg·yr) after selection of the fully contained events. This background index is reduced to ∼4×10$^{−5}$ counts/(keV·kg·yr) by applying a topological selection requiring only one double-electron-like track in the events. This value is one order of magnitude below the total radiogenic background expectation in NEXT-100. By analyzing the correlation of the airborne radon activity and the measured rate of events in NEXT-100, it is concluded that the detector operates in a virtually radon-free environment thanks to the radon abatement system of the LSC.[graphic not available: see fulltext]

Cortes-Parra, C. [Valencia U., IFIC] (ORCID:000000↗
DOE OSTI2025

Barium ion sensing with IPG K + molecular probes

Fluorophores covalently bound to azacrown ether ionophores can be assembled into sensitive turn-on chemosensors. The size specificity and electron-rich nature of the ionophore's binding domain contribute to both selectivity and strong turn-on fluorescence sensing by various mechanisms when properly constructed. Aza-18-crown-6 ethers are quite selective for binding to K + and Ba 2+ , yet the more electron-withdrawing dicationic nature of barium imposes a larger electronic effect on turn-on fluorescent sensors. Barium chemosensors can be important for measuring soluble Ba 2+ in drinking water and have gained recent attention for their potential to enhance the detection of rare events in xenon decay. Here we quantify the capability of three chemosensors, marketed for biologically useful K + sensing, as effective probes for Ba 2+ ions. Here, we present measurements from bulk spectrofluorometry to characterize the system in aqueous solutions and demonstrate the usefulness of these species for low-background single-ion fluorescence microscopy, revealing new candidates for Ba 2+ sensing.

Miller, R. L. [Department of Chemistry and Biochem↗
DOE OSTI2025

Demonstration of Sub-Percent Energy Resolution in the NEXT-100 Detector

NEXT-100 is a high-pressure xenon time projection chamber with electroluminescent amplification, designed to operate with up to approximately 70.5 kg at 13.5 bar. It is the most recent detector developed by the NEXT collaboration to search for the neutrinoless double-beta decay ($ββ0ν$) of Xe-136. The NEXT gas TPC technology offers the best energy resolution near the Q-value of the decay ($Q_{ββ}$ = 2458 keV) among xenon detectors, which is set by design to be <1% FWHM. We report here the high-energy calibration of the detector using a Th-228 source, demonstrating linear response and an energy resolution of $(0.90 \pm 0.02)$% FWHM at the Tl-208 photopeak (2615 keV). This performance extrapolates to a resolution at the double-beta decay end-point of $R(Q_{ββ})$ = $(0.93 \pm 0.02)$% FWHM, confirming the detector's capability for precision energy measurement in the search for $ββ0ν$.

Pérez Maneiro, M. [Santiago de Compostela U., IGFA↗
DOE OSTI2026

High voltage delivery and distribution for the NEXT-100 Time Projection Chamber

A critical element in the realization of large liquid andgas time projection chambers (TPCs) is the delivery and distributionof high voltages into and around the detector. Such experimentsrequire of order tens of kilovolts to enable electron drift overmeter-scale distances. This paper describes the design andoperation of the cathode feedthrough and high voltage distributionthrough the field cage of the NEXT-100 experiment, an undergroundTPC that will search for neutrinoless double beta decay0νββ. The feedthrough has been demonstrated to holdpressures up to 20 bar and sustain voltages as high as -65 kV.The TPC is operating stably at its design high voltages. The systemhas been realized within the constraints of a stringent radiopuritybudget and is now being used to execute a suite of sensitive doublebeta decay analyses.

Adams, C. [Argonne]↗
DOE OSTI2026

Electroluminescence Yield Measurements in Xenon Gas with the NEXT-DEMO++ Detector

The NEXT-DEMO++ detector, a high-pressure xenon gas time projection chamber serving as a prototype for the NEXT-100 experiment, was used to measure the electroluminescence (EL) yield as a function of reduced electric field ($E/p$) across pressures from 2.0 to 9.4 bar, utilizing the 41.5 keV de-excitation peak of $^{83m}$Kr. These measurements were made to examine the pressure dependence of the slope of the reduced EL yield $Y/p$, which has shown inconsistencies in the literature. The reduced yield was fitted with a linear model, revealing a modest ($\sim$5%) change in slope, beginning around 5 bar and increasing with pressure up to 9.4 bar.

Renner, J. [Valencia U., IFIC]↗
DOE OSTI2025

Integrated multi-omic characterizations of the synapse reveal RNA processing factors and ubiquitin ligases associated with neurodevelopmental disorders

The molecular composition of the excitatory synapse is incompletely defined due to its dynamic nature across developmental stages and neuronal populations. To address this gap, we apply proteomic mass spectrometry to characterize the synapse in multiple biological models including the fetal human brain and hiPSC-derived neurons. To prioritize the identified proteins, we develop an orthogonal multi-omic screen of genomic, transcriptomic, interactomic, and structural data. This data-driven framework identifies proteins with key molecular features intrinsic to the synapse, including characteristic patterns of biophysical interactions and cross-tissue expression. The multi-omic analysis captures synaptic proteins across developmental stages and experimental systems, including 493 synaptic candidates supported by proteomics. We further investigate three such proteins that are associated with neurodevelopmental disorders – the CUL3 E3 ubiquitin ligase, the DDX3X and YBX1 nucleic-acid binding proteins – by mapping their networks of physically interacting synapse proteins or transcripts. Our study demonstrates the potential of an integrated multi-omic approach to systematically and more comprehensively resolve the synaptic architecture.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2025

Characterizing and controlling CRISPR repair outcomes in nondividing human cells

Genome editing is poised to revolutionize treatment of genetic diseases, but poor understanding and control of DNA repair outcomes hinders its therapeutic potential. DNA repair is especially understudied in nondividing cells like neurons, limiting the efficiency and precision of genome editing in many clinically relevant tissues. Here, we address this barrier by using induced pluripotent stem cells (iPSCs) and iPSC-derived neurons to examine how postmitotic human neurons repair Cas9-induced DNA damage. CRISPR editing outcomes differ dramatically in neurons compared to genetically identical dividing cells: neurons take longer to fully resolve this damage, and upregulate non-canonical DNA repair factors in the process. Manipulating this response with chemical or genetic perturbations allows us to direct DNA repair toward desired editing outcomes in nondividing human neurons, cardiomyocytes, and primary T cells. By studying DNA repair in clinically relevant cells, we reveal unforeseen challenges and opportunities for precise therapeutic editing.

Ramadoss, Gokul N. [Gladstone Institutes, San Fran↗
DOE OSTI2025

Sequential membrane- and protein-bound organelles compartmentalize genomes during phage infection

Many eukaryotic viruses require membrane-bound compartments for replication, but no such organelles are known to be formed by prokaryotic viruses. Bacteriophages of the Chimalliviridae family sequester their genomes within a phage-generated organelle, the phage nucleus, which is enclosed by a lattice of the viral protein ChmA. We show that inhibiting phage nucleus formation arrests infections at an early stage in which the injected phage genome is enclosed within a membrane-bound early phage infection (EPI) vesicle. Early phage genes are expressed from the EPI vesicle, demonstrating its functionality as a prokaryotic, transcriptionally active, membrane-bound organelle. We also show that the phage nucleus is essential, with genome replication beginning after the injected DNA is transferred from the EPI vesicle to the phage nucleus. Our results show that Chimalliviridae require two sophisticated subcellular compartments of distinct compositions and functions that facilitate successive stages of the viral life cycle.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2026

Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants

Although KRAS G12C -specific inhibitors have been introduced, no approved targeted therapies exist for other clinically significant KRAS mutants, including KRAS G12D and KRAS G12V . We discovered BBO-11818, a potent, selective, orally bioavailable noncovalent pan-KRAS inhibitor capable of targeting multiple KRAS mutants in both the inactive GDP-bound (OFF) and active GTP-bound (ON) states. BBO-11818 binds in the Switch-II/Helix 3 pocket, inducing conformational changes incompatible with effector binding, and demonstrates high-affinity binding to mutant KRAS with strong selectivity over NRAS and HRAS. BBO-11818 potently inhibited MAPK signaling and cellular viability specifically in KRAS-driven lines and produced tumor regressions in KRAS-mutant xenograft models. Combination studies with anti–PD-1, anti-EGFR antibodies, and a RAS:PI3Kα breaker compound showed enhanced efficacy. BBO-11818 has entered phase I clinical trials for patients with various KRAS mutations in colorectal, pancreatic, and lung cancers (NCT06917079).

Stahlhut, Carlos [BridgeBio Oncology Therapeutics,↗
DOE OSTI2026

Detection of scintillation light in noble gases with wavelength-shifting optical fibers

Wavelength-shifting (WLS) techniques enable particle detectors based on noble gases, whose scintillation light is predominantly emitted in the vacuum-ultraviolet. We investigate WLS fibers coated with tetraphenyl butadiene (TPB) for scintillation light detection in gaseous xenon and argon at pressures up to 8.5 bar, motivated by future high-pressure xenon time-projection chambers of the NEXT program. Two detector configurations are studied: an elongated high-pressure vessel with four PTFE panels equipped with WLS fibers read by temperature-stabilized SiPMs, and a compact box-shaped detector operated at 1 bar Xe with WLS fibers read out by PMTs. Both operate with continuous gas purification. The detector response is characterized using cosmic muons and alpha particles from a $^{241}$Am source. With the SiPM setup, we measure a light collection efficiency (LCE) of ${1.18 \pm 0.01~\mathrm{(sta.)}~^{+0.07}_{-0.09}~\mathrm{(sys.)}~\%}$ for xenon and ${1.07 \pm 0.01~\mathrm{(sta.)}~^{+0.06}_{-0.08}~\mathrm{(sys.)}~\%}$ for argon. With PMT readout, we measure a LCE of ${0.45 \pm 0.01~\mathrm{(sta.)} \pm 0.05~\mathrm{(sys.)}~\%}$ in xenon, in agreement with the SiPM result once photon detection efficiency is accounted for. Average scintillation waveforms in xenon and argon are studied to assess the time structure of the emitted light. Cosmic-muon measurements yield a mean energy required to produce a scintillation photon $45\pm7~\mathrm{(sta.)}~^{+4}_{-5}~\mathrm{(sys.)}~\mathrm{eV}$ at 1.5 bar, in agreement with the literature. The results demonstrate that TPB-coated WLS fiber systems can reliably detect scintillation light in high-pressure gaseous noble detectors, with a LCE representing an upper limit for realistic large-scale TPCs, where additional photon losses from materials and fiber attenuation are expected.

Soleti, S. R. [Donostia Intl. Phys. Ctr., San Seba↗
DOE OSTI2025

BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction

BBO-10203 is an orally available drug that covalently and specifically binds to the rat sarcoma (RAS)–binding domain of phosphoinositide 3-kinase α (PI3Kα), preventing its activation by HRAS, NRAS, and KRAS. Here, it inhibited PI3Kα activation in tumors with oncogenic mutations in KRAS or PIK3CA and in tumors with human epidermal growth factor receptor 2 (HER2) amplification or overexpression. In preclinical models, BBO-10203 caused significant tumor growth inhibition across multiple tumor types and showed enhanced efficacy in combination with inhibitors of cyclin-dependent kinase 4/6 (CDK4/6), estrogen receptor (ER), HER2, and KRAS-G12C mutant, including in tumors harboring mutations in Kelch-like ECH-associated protein 1 (KEAP1) and serine/threonine kinase 11 (STK11). Notably, these antitumor effects occurred without inducing hyperglycemia, because insulin signaling does not depend on RAS-mediated PI3Kα activation to promote glucose uptake.

Simanshu, Dhirendra K. [Frederick National Laborat↗